CGNT News & Events

The major averages closed broadly higher following reports that the U.S. has provided a plan to Iran to bring the war to an end, which sent oil prices lower. The Associated Press reported that Iran was given a 15-point proposal from the U.S. to end the conflict, though media have reported that the two sides remain far apart on a resolution and attacks from both sides have continued.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:MerckTerns Pharmaceuticalsfor $53 per share in cashElon Musk's SpaceX will file an IPO prospectus as soon as this week or next,Armexpectsfrom its chips unit in five yearsChewyreportedand provided its outlook for Q1 and FY26JetBlueis exploring a potential merger with rivals,2. WALL STREET CALLS:Armto Outperform from Market Perform at Raymond JamesWolfeGeneral Motorson underappreciated potential tailwindsWedbushRezoluteas worst case scenario seems unlikely for cHIMondelezto Neutral from Buy at Rothschild & Co RedburnEVgowith Neutral from Overweight at JPMorgan3. AROUND THE WEB:Salesforceis skipping raises for its director-level and above employees, Insider reportsA jury found Metaand Googleliable in a social media addiction trial, Reuters saysMeanwhile, Metawill lay off "a few hundred people" across the company on Wednesday, The Information saysSK Hynixplans to spend about $8B on cutting-edge EUV lithography chipmaking tools from ASMLthrough 2027, Bloomberg saysInteland AMDhave each told customers they plan to raise prices across their entire CPU product lines starting in March and April, Nikkei reports4. MOVERS:Sareptarose after announcingfrom Phase 1/2 ascending dose studies of SRP-1001 and SRP-1003Brazegained afterand authorizing a stock repurchase program of up to $100MApogee Therapeuticsfinished higher after announcing aMaze Therapeuticsclosed lower afterand announcing data from its Phase 2 HORIZON trialAdma Biologicsfell for another session afterfrom Culper Research5. EARNINGS/GUIDANCE:Paychexand reaffirmed its guidance for FY26EDAP TMSand backed its guidance for FY26Cognyte, with EPS beating consensusCintasand raised its guidance for FY26QT Imagingand reaffirmed guidance for FY26INDEXES:The Dow rose 305.43, or 0.66%, to 46,429.49, the Nasdaq gained 167.93, or 0.77%, to 21,929.83, and the S&P 500 advanced 35.53, or 0.54%, to 6,591.90.

The major averages were broadly higher near noon following reports that the U.S. has provided a plan to Iran to bring the war to an end, which sent oil prices lower. The Associated Press reported that Iran was given a 15-point proposal from the U.S. to end the conflict, though media have reported that the two sides remain very far apart and attacks from both sides have continued.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:MerckTerns Pharmaceuticalsfor $53 per share in cashElon Musk's SpaceX will file an IPO prospectus as soon as this week or next,Armexpectsfrom its chips unit in five yearsChewyreportedand provided its outlook for Q1 and FY26Beretta willfor 20.05% of Sturm Rugershares2. WALL STREET CALLS:Armto Outperform from Market Perform at Raymond JamesWolfeGeneral Motorson underappreciated potential tailwindsWedbushRezoluteas worst case scenario seems unlikely for cHIMondelezto Neutral from Buy at Rothschild & Co RedburnEVgowith Neutral from Overweight at JPMorgan3. AROUND THE WEB:Finland has suspended a plan to move its election platform to Amazon Web Services, opting to remain on domestic servers through the 2027 general election, Bloomberg reportsSK Hynixplans to spend about $8B on cutting-edge EUV lithography chipmaking tools from ASMLthrough 2027, Bloomberg saysClear Secureapp downloads have surged, with passengers downloading the app 289,000 times since the beginning of March, as travelers face long TSA lines amid a partial government shutdown, WSJ reportsInteland AMDhave each told customers they plan to raise prices across their entire CPU product lines starting in March and April, Nikkei reportsMeta Platformswill lay off "a few hundred people" across the company on Wednesday, The Information says4. MOVERS:Sareptaincreases after announcingfrom Phase 1/2 ascending dose studies of SRP-1001 and SRP-1003Brazegains afterand authorizing a stock repurchase program of up to $100MApogee Therapeuticshigher after announcing aMaze Therapeuticslower afterand announcing data from its Phase 2 HORIZON trialAdma Biologicsfalls after addressing the5. EARNINGS/GUIDANCE:Paychexand reaffirmed its guidance for FY26EDAP TMSand backed its guidance for FY26Cognytewith EPS beating consensusCintasand raised its guidance for FY26QT Imagingand reaffirmed guidance for FY26INDEXES:Near midday, the Dow was up 0.62%, or 287.95, to 46,412.01, the Nasdaq was up 0.80%, or 173.04, to 21,934.94, and the S&P 500 was up 0.59%, or 38.91, to 6,595.28.

Reports Q4 revenue $106.2M, consensus $106.28M. "Cognyte's mission - to help make the world a safer place - continues to guide everything we do," said Elad Sharon, Cognyte's chief executive officer. "We translated that mission into strong growth, higher margins and improved profitability. At the same time, we continued to advance our technology, particularly in AI-driven analytics, enabling our customers to make faster and more effective decisions in critical moments. As global threats become more complex and dynamic, the need for trusted, mission-critical intelligence is increasing. We believe Cognyte is well positioned at the intersection of data, analytics and operational impact, and we remain confident in our path toward our fiscal 2028 targets."

Sees FY27 revenue $448M, with a range of +/- 3%, which represents approximately 12% year-over-year growth at the midpoint of the range, consensus $442.6M